New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
10:02 EDTCOTY, TEVA, RGP, EGHT, BIN, WWAV, NMBL, ACMP, JAH, TEX, TCO, SGNT, AGN, CQP, MYL, PRGO, O, AKRX, ACT, ACRX, ANIPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ANI Pharmaceuticals (ANIP) initiated with a Buy at Roth Capital... AcelRx (ACRX) initiated with an Outperform at RBC Capital... Actavis (ACT) initiated with an Outperform at RBC Capital... Akorn (AKRX) initiated with an Outperform at RBC Capital... Allergan (AGN) initiated with an Outperform at RBC Capital... Cheniere Energy Partners (CQP) initiated with an Outperform at Credit Suisse... Mylan (MYL) initiated with an Outperform at RBC Capital... Perrigo (PRGO) initiated with a Top Pick at RBC Capital... Realty Income (O) initiated with an Outperform at Oppenheimer... Sagent Pharmaceuticals (SGNT) initiated with an Underperform at RBC Capital... Taubman Centers (TCO) initiated with a Perform at Oppenheimer... Terex (TEX) initiated with a Hold at Jefferies... Teva (TEVA) initiated with a Sector Perform at RBC Capital... Regency Energy Partners (RGP) reinstated with an Outperform at Credit Suisse... 8x8, Inc. (EGHT) initiated with a Buy at Needham... Progressive Waste (BIN) initiated with an Underperform at Macquarie... WhiteWave Foods (WWAV) reinstated with an Overweight at JPMorgan... Nimble Storage (NMBL) initiated with a Buy at Stifel... Access Midstream (ACMP) coverage assumed with an Outperform at Credit Suisse... Jarden (JAH) initiated with an Outperform at RBC Capital... Coty (COTY) initiated with a Sector Perform at RBC Capital.
News For ANIP;ACRX;ACT;AKRX;AGN;CQP;MYL;PRGO;O;SGNT;TCO;TEX;TEVA;RGP;EGHT;BIN;WWAV;NMBL;ACMP;JAH;COTY From The Last 14 Days
Check below for free stories on ANIP;ACRX;ACT;AKRX;AGN;CQP;MYL;PRGO;O;SGNT;TCO;TEX;TEVA;RGP;EGHT;BIN;WWAV;NMBL;ACMP;JAH;COTY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
September 9, 2014
17:06 EDTACTFDA panel votes against Actavis blood pressure pill, Bloomberg says
FDA advisers said that Actavis's experimental pill that combines two existing drugs to lower high blood pressure doesn’t provide a clinically meaningful benefit over the two drugs alone, says Bloomberg. The advisory panel voted 6 to 4 against recommending the treatment, added Bloomberg. Shares of Actavis are trading down almost 1% in after-hours trading. Reference Link
16:04 EDTAGNPershing Square reports 9.7% stake in Allergan, sends letter to board
Pershing Square Capital Management sent a letter to the board of Allergan that highlights several reasons why Allergan is extremely shareholder unfriendly and why now is the time for Allergan's management team to wake up. In the letter, Pershing Square said: "Since the bid was announced in April, 75% of Allergan’s shareholders have sold all or a portion of their investment including the company’s largest shareholder, which has sold its entire position. These shareholders are sending the board a message. They would not have sold if they believed that Allergan stock was worth more than current values... We note CFO Jeff Edwards recent decision to retire from the company at age 53 for family reasons, and his replacement by an investor relations executive rather than an experienced public company CFO. The notion that Allergan should execute the largest acquisition in its history led by an investor relations executive is a frightening proposition. While we respect an executive’s need to retire from a company for family reasons, Edwards exit also calls into question the company’s forward earnings guidance which shareholders expected him to execute on when the Company presented these projections on July 21st. I had expected that at some point one or more directors would have woken up and smelled the coffee. There is still time for a subset of directors to rescue their reputations by taking over leadership of this process from David Pyott and his handpicked advisors and doing what you are paid $400,000 per year to do on behalf of the company’s owners."
12:10 EDTWWAVOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday after opening in the red and trading in a narrow range throughout the morning. The domestic economic calendar only had two reports of consequence, and neither was particularly market moving. All eyes are on Cupertino, California, where Apple (AAPL) will shortly begin its much-anticipated product launch event. ECONOMIC EVENTS: In the U.S., the NFIB small business optimism survey for August came in at 96.1, which was above the expected 96.0 reading. The Job Openings and Labor Turnover Survey, or JOLTS report, showed job openings slipped 2K to about 4.67M in July. COMPANY NEWS: Shares of Apple were up 1% near noon ahead of the tech giant's latest product launch event, which is scheduled to begin at 1 pm ET. Expectations are for the company to introduce the iPhone 6, which has widely been speculated to be bigger than past members of the line-up and may come in 4.7 inch and 5.5 inch sizes. The company is also expected to unveil a wearable device, likely a smartwatch, and a mobile payment system integrated with both... Shares of fast food giant McDonald’s (MCD) slid 1% after reporting its comparable sales were down 3.7% worldwide in August and that its China supplier issue will negatively impact its Q3 EPS by 15c-20c. MAJOR MOVERS: Among the notable gainers was Annies (BNNY), which surged 38% after prepared foods giant General Mills (GIS) last night said that it had agreed to buy the mac and cheese maker for $820M, or $46 per share in cash. Shares of a number of other natural food makers climbed after the deal, as WhiteWave (WWAV) rose nearly 3% and Boulder Brands (BDBD) jumped over 8%. Following the deal announcement, shares of General Mills slipped about 0.5%. Among the noteworthy losers was Leidos (LDOS), which dropped 15% after the company reported lower than expected second quarter earnings and cuts its EPS view for the fiscal year. Also lower was MaxLinear (MXL), which fell 15% after the company said several of its cable and satellite customers have requested push-outs of shipments, resulting in the company lowering its Q3 revenue outlook and Needham downgrading the stock to Buy from Strong Buy. INDEXES: Near midday, the Dow was down 69.02, or 0.4%, to 17,042.40, the Nasdaq was down 14.93, or 0.33%, to 4,577.35, and the S&P 500 was down 6.74, or 0.34%, to 1,994.80.
10:18 EDTACTDollar General listed among 5 largest long positions by Jana Partners
Subscribe for More Information
10:12 EDTWWAVNatural food makers rise following Annies acquisition
Shares of a number of natural food makers are climbing after one of the companies in the sector, Annies (BNNY), announced last night that it agreed to be acquired by General Mills (GIS). In a note to investors today, research firm Oppenheimer wrote that the deal should cause the valuations of two natural food makers, Boulder Brands (BDBD) and WhiteWave (WWAV), to rise in the near-term. WHAT'S NEW: General Mills last night said that it had agreed to buy Annie's for $46 per share in cash, or $820M. Annies' stock closed yesterday at $33.51. General Mills expects the transaction to be accretive to its earnings in the first 12 months following the completion of the deal. ANALYST REACTION: In a note to investors today, Oppenheimer analyst Rupesh Parikh wrote that the acquisition of Annie's could cause the valuations of stocks in the natural foods sector to rise significantly. The terms of the acquisition of Annies imply a nearly 40x P/E multiple to consensus FY15 forecasts for the company, according to Parikh. The shares of Boulder Brands and WhiteWave should advance in the near-term, added the analyst, who kept Outperform ratings on both names PRICE ACTION: In early trading, WhiteWave rose 3.9% to $37.10, while Boulder Brands jumped 7.6% to $14.25. Another stock in the sector, Hain Celestial (HAIN), advanced 3.5% to $101.17, while Annies surged 37% to $46 and General Mills slipped 0.5% to $53.26.
09:12 EDTWWAVOn The Fly: Pre-market Movers
Subscribe for More Information
08:02 EDTWWAVBoulder Brands WhiteWave Foods could be lifted by Annie's deal, says Oppenheimer
Subscribe for More Information
06:42 EDTMYL, AGNLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
September 8, 2014
18:31 EDTWWAVOn The Fly: After Hours Movers
UP AFTER EARNINGS: Casey's General Stores (CASY), up 3.6%... Korn/Ferry (KFY), up 2.8%. ALSO HIGHER: Annies (BNNY), up 37.3% after General Mills (GIS) announced it will acquire the company for $46 per share... General Mills is trading just under 1% higher... Following the Annies/General Mills announcement, Hain Celestial Group (HAIN) is 3.6% higher, WhiteWave Foods (WWAV) is up 6.3%, and Boulder Brands (BDBD) is up 8.7%... iPass (IPAS), up 35.1% after announcing that it is exploring strategic alternatives... CTI BioPharma (CTIC), up 8.1% after being initiated with an Overweight at Piper Jaffray... Threshold Pharmaceuticals (THLD), up 5% after being initiated with a Buy at Cantor. DOWN AFTER EARNINGS: Pep Boys (PBY), down 6.7% following second quarter miss. ALSO LOWER: Pinnacle Foods (PF), down 3.7% after filing an automatic common stock shelf and announcing the sale of 15M shares of common stock for holders... Physicians Realty Trust (DOC), down 4.9% after offering 9M common shares.
17:50 EDTWWAVFood product stocks higher after General Mills acquires Annie's
Subscribe for More Information
12:40 EDTTEVAFTC sues AbbVie over blocking of AndroGel generics
The Federal Trade Commission has filed a complaint in federal district court charging several pharmaceutical companies with "illegally blocking American consumers’ access to lower-cost versions of the blockbuster drug AndroGel." The FTC's complaint alleges that AbbVie (ABBV) and its partner Besins Healthcare filed baseless patent infringement lawsuits against potential generic competitors to delay the introduction of lower-priced versions of the testosterone replacement drug AndroGel. While the lawsuits were pending, AbbVie then entered into an anticompetitive pay-for-delay settlement agreement with Teva Pharmaceuticals (TEVA) to further delay generic drug competition, the FTC claims. Reference Link
11:05 EDTMYLOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
10:04 EDTMYLMylan calls active on activist investor speculation
Subscribe for More Information
09:57 EDTMYLRumor: Mylan moves up on activist investor speculation
Subscribe for More Information
09:27 EDTTEVA, MYLLeerink biotech analyst holds a luncheon meeting with a conference call
Biotech Analyst Schwartz provides an update on key trends and controversies for marketed MS therapies and discusses new data presented at ACTRIMS-ECTRIMS at a Luncheon Meeting with an Analyst/Industry conference call to be held in Boston on September 11 at 12:15 pm.
08:45 EDTNMBLNimble Storage, Arista, CommVault recommnded on M&A at Pacific Crest
Subscribe for More Information
08:09 EDTNMBLNimble Storage initiated with an Outperform at FBN Securities
Subscribe for More Information
08:02 EDTTEVATeva completes Reslizumab Phase III program
Subscribe for More Information
07:21 EDTAGNJazz looks more attractive for Allergan than Salix, says Wells Fargo
Subscribe for More Information
07:03 EDTMYLMylan annoucnes court grants summary judgment in favor of company
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use